Learning Objectives:

•Understand how transcriptional profiling can partially resolve DLBCL heterogeneity
•Understand how transcriptional profiling may identify DLBCLs susceptible to select targeted and immune therapies
Session date: 
01/06/2025 - 12:00pm to 1:00pm CST
Add to calendar: 
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation
Please login or create an account to proceed.
Speaker Name: 
Justin Kline, MD